CBER Cell Therapies Office Director Is Former Intronn, Genetic Therapy Exec Otto
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA names former Intronn Chief Operating Office Otto to head Office of Cellular, Tissue & Gene Therapies, effective Nov. 14. Otto also served as COO of Genetic Therapy, Inc.